Evaluation of the prognostic value of the ESTRO EORTC classification of oligometastatic disease in patients treated with stereotactic body radiotherapy: A retrospective single center studyJonas Willmann, Nicolaus Andratschke, Selma Adilovic et al.|Radiotherapy and Oncology|2022Cited by 46
Distant Metastasis Velocity as a Novel Prognostic Score for Overall Survival After Disease Progression Following Stereotactic Body Radiation Therapy for Oligometastatic DiseaseJonas Willmann, Nicolaus Andratschke, Selma Adilovic et al.|International Journal of Radiation Oncology*Biology*Physics|2022Cited by 18
Repeat stereotactic body radiotherapy for oligometastatic diseaseJonas Willmann, Nicolaus Andratschke, Selma Adilovic et al.|Radiotherapy and Oncology|2023Cited by 12
Stereotactic body radiotherapy to defer systemic therapy in patients with oligorecurrent diseaseJonas Willmann, Nicolaus Andratschke, Selma Adilovic et al.|Clinical and Translational Radiation Oncology|2022Cited by 11